Total Access Medical

Alzheimer's

Read practical health and wellness guidance from Total Access Medical.

FDA Advisers endorse Early-Stage Alzheimer’s Drug, Donanemab

The FDA voted to endorse donanemab, a monoclonal antibody that is designed to slow the development of early symptomatic Alzheimer disease.

Read the Article

Is It Alzheimer's Disease or Dementia?

Learning about the two terms and the difference between them is important and can empower individuals living with Alzheimer’s or another dementia, their families and their caregivers with necessary knowledge.

Medicine as it was meant to be.

Membership is limited. Your doctor should feel like your doctor, and your personal care should be personal. Call us or send a message to learn how enrolling in a Total Access Medical program can change your life.

Questions? Speak directly with our team

610-667-9980